, ,
Presentations this author is a contributor to:
ARE PATIENTS WITH RESECTABLE RECTAL CANCER BETTER OFF IN THE ERA OF MULTIDISCIPLINARY CARE? (#154)
2:50 PM
Vy Broadbridge
Free Communications - ProbeNet/ACCG
A PHASE IB STUDY OF SECOND-LINE THERAPY WITH PANITUMUMAB, IRINOTECAN AND EVEROLIMUS (PIE) IN METASTATIC COLORECTAL CANCER (mCRC) WITH KRAS WILD TYPE (WT) (#430)
12:00 PM
Amanda R Townsend
ACCG/ProbeNet Poster Presentations II - Colorectal